HROW Harrow Health Inc

Price (delayed)

$10.38

Market cap

$367.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.75

Enterprise value

$483.48M

Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton ...

Highlights

HROW's revenue is up by 47% year-on-year and by 14% since the previous quarter

HROW's gross profit is up by 43% YoY and by 14% QoQ

Harrow Health's equity has soared by 156% YoY but it has decreased by 7% from the previous quarter

Harrow Health's net income has plunged by 73% YoY and by 72% from the previous quarter

Harrow Health's debt has soared by 70% YoY

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Website: http://www.harrowinc.com

Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of HROW

Market

Shares outstanding

35.36M

Market cap

$367.06M

Enterprise value

$483.48M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

5.15

Price to sales (P/S)

2.6

EV/EBIT

N/A

EV/EBITDA

48.57

EV/Sales

3.71

Earnings

Revenue

$130.19M

EBIT

-$2.39M

EBITDA

$9.95M

Free cash flow

$2.38M

Per share

EPS

-$0.75

Free cash flow per share

$0.07

Book value per share

$2.02

Revenue per share

$3.99

TBVPS

$4.59

Balance sheet

Total assets

$312.16M

Total liabilities

$241.75M

Debt

$190.5M

Equity

$70.77M

Working capital

$90.14M

Liquidity

Debt to equity

2.69

Current ratio

2.83

Quick ratio

2.41

Net debt/EBITDA

11.7

Margins

EBITDA margin

7.6%

Gross margin

69.6%

Net margin

-18.7%

Operating margin

0.3%

Efficiency

Return on assets

-9.4%

Return on equity

-51.2%

Return on invested capital

-1.1%

Return on capital employed

-0.9%

Return on sales

-1.8%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

HROW stock price

How has the Harrow Health stock price performed over time

Intraday

-2.44%

1 week

-1.42%

1 month

-20.76%

1 year

-59.28%

YTD

-7.32%

QTD

-21.54%

Financial performance

How have Harrow Health's revenue and profit performed over time

Revenue

$130.19M

Gross profit

$90.55M

Operating income

$431,000

Net income

-$24.41M

Gross margin

69.6%

Net margin

-18.7%

HROW's operating margin has dropped by 90% since the previous quarter and by 86% year-on-year

Harrow Health's operating income has plunged by 88% from the previous quarter and by 78% YoY

Harrow Health's net income has plunged by 73% YoY and by 72% from the previous quarter

Harrow Health's net margin has plunged by 51% from the previous quarter and by 18% YoY

Growth

What is Harrow Health's growth rate over time

Valuation

What is Harrow Health stock price valuation

P/E

N/A

P/B

5.15

P/S

2.6

EV/EBIT

N/A

EV/EBITDA

48.57

EV/Sales

3.71

The EPS has dropped by 67% since the previous quarter and by 47% year-on-year

Harrow Health's equity has soared by 156% YoY but it has decreased by 7% from the previous quarter

The stock's price to book (P/B) is 80% less than its 5-year quarterly average of 26.4 and 69% less than its last 4 quarters average of 16.7

HROW's P/S is 47% below its last 4 quarters average of 4.9 and 30% below its 5-year quarterly average of 3.7

HROW's revenue is up by 47% year-on-year and by 14% since the previous quarter

Efficiency

How efficient is Harrow Health business performance

The ROIC has plunged by 141% from the previous quarter but it has soared by 82% YoY

The return on sales has dropped by 140% since the previous quarter but it has surged by 76% year-on-year

Harrow Health's return on equity has surged by 59% YoY but it has decreased by 33% QoQ

The return on assets has declined by 47% since the previous quarter but it is up by 25% year-on-year

Dividends

What is HROW's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for HROW.

Financial health

How did Harrow Health financials performed over time

The total assets is 29% greater than the total liabilities

The total assets has soared by 98% year-on-year and by 9% since the previous quarter

HROW's total liabilities has surged by 86% year-on-year and by 15% since the previous quarter

Harrow Health's debt is 169% more than its equity

Harrow Health's equity has soared by 156% YoY but it has decreased by 7% from the previous quarter

Harrow Health's debt has soared by 70% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.